TABLE 2.
QBB4‐1 demographics and baseline characteristics by rescue medication use.
| Characteristics | Without rescue medication | With rescue medication | Total |
|---|---|---|---|
| n (%) | 62 (46.3) | 72 (53.7) | 134 (100.0) |
| Sex (n [%]) | |||
| Men | 30 (48.4) | 38 (52.8) | 68 (50.7) |
| Women | 32 (51.6) | 34 (47.2) | 66 (49.3) |
| Age (years, mean ± SD) | 8.5 ± 4.0 | 8.1 ± 3.6 | 8.3 ± 3.8 |
| Duration of AD (years, mean ± SD) | 5.7 ± 3.7 | 6.2 ± 3.7 | 6.0 ± 3.7 |
| mEASI score BL (mean ± SD) | 9.5 ± 5.1 | 11.9 ± 5.5 | 10.8 ± 5.4 |
| IGA score BL (n [%]) | |||
| 2 (mild) | 23 (37.1) | 7 (9.7) | 30 (22.4) |
| 3 (moderate) | 28 (45.2) | 43 (59.7) | 71 (53.0) |
| 4 (severe) | 11 (17.7) | 22 (30.6) | 33 (24.6) |
Abbreviations: AD, atopic dermatitis; BL, baseline; IGA, investigator’s global assessment; mEASI, modified eczema area and severity index; SD, standard deviation.